T.Man Pharmaceutical Future Growth
Future criteria checks 2/6
T.Man Pharmaceutical is forecast to grow earnings and revenue by 17.4% and 11.7% per annum respectively while EPS is expected to grow by 3.5% per annum.
Key information
17.4%
Earnings growth rate
3.5%
EPS growth rate
| Pharmaceuticals earnings growth | 16.7% |
| Revenue growth rate | 11.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,516 | 536 | 183 | 514 | 1 |
| 12/31/2024 | 2,209 | 452 | 128 | 414 | 1 |
| 9/30/2024 | 2,197 | 433 | 313 | 514 | N/A |
| 6/30/2024 | 2,130 | 419 | 239 | 416 | N/A |
| 3/31/2024 | 2,055 | 425 | 151 | 349 | N/A |
| 12/31/2023 | 1,980 | 431 | 62 | 282 | N/A |
| 9/30/2023 | 1,903 | 416 | 97 | 387 | N/A |
| 6/30/2023 | 1,982 | 494 | 269 | 597 | N/A |
| 3/31/2023 | 2,003 | 483 | 279 | 560 | N/A |
| 12/31/2022 | 2,025 | 473 | 289 | 524 | N/A |
| 12/31/2021 | 1,263 | 56 | 196 | 276 | N/A |
| 12/31/2020 | 901 | 60 | 129 | 194 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMAN-R's forecast earnings growth (17.4% per year) is above the savings rate (2%).
Earnings vs Market: TMAN-R's earnings (17.4% per year) are forecast to grow slower than the TH market (17.6% per year).
High Growth Earnings: TMAN-R's earnings are forecast to grow, but not significantly.
Revenue vs Market: TMAN-R's revenue (11.7% per year) is forecast to grow faster than the TH market (6.9% per year).
High Growth Revenue: TMAN-R's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TMAN-R's Return on Equity is forecast to be high in 3 years time